Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: Issues and recommendations. A Rome Foundation working team report

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 9, 2014, Pages 1094-1102

  Sperber, A D ^a   Gwee, K A ^b   Hungin, A P ^c   Corazziari, E ^d   Fukudo, S ^e   Gerson, C ^f   Ghoshal, U C ^g   Kang, J Y ^h   Levy, R L ⁱ   Schmulson, M ^j   Dumitrascu, D ^k   Gerson, M J ^l   Chen, M ^m   Myung, S J ⁿ   Quigley, E M M ^o   Whorwell, P J ^p   Zarzar, K ^q   Whitehead, W E ^r  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DURHAM UNIVERSITY   (United Kingdom)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^h ST GEORGE S HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^k IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^l NEW YORK UNIVERSITY   (United States)

^m SUN YAT SEN UNIVERSITY   (China)

ⁿ University of Ulsan College of Medicine   (South Korea)

^o HOUSTON METHODIST HOSPITAL   (United States)

^p WYTHENSHAWE HOSPITAL   (United Kingdom)

^q TransPeerfect   (United States)

^r UNIVERSITY OF NORTH CAROLINA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CROSS CULTURAL RESEARCH; DIGESTIVE SYSTEM FUNCTION DISORDER; DOCUMENTATION; HEALTH CARE AVAILABILITY; HEALTH CARE PLANNING; HEALTH SERVICE; HUMAN; INTERVENTION STUDY; MULTINATIONAL RESEARCH; PATIENT SELECTION; PREVALENCE; RESEARCH; SAMPLING; STATISTICAL ANALYSIS; STUDY DESIGN; TEAMWORK; TREATMENT OUTCOME; VALIDATION STUDY; COMORBIDITY; CULTURAL FACTOR; ETHNOLOGY; GASTROINTESTINAL DISEASES; INTERNATIONAL COOPERATION; ITALY; MEDICAL RESEARCH; NON PROFIT ORGANIZATION; PROCEDURES; QUALITY OF LIFE; STANDARDS;

BIOMEDICAL RESEARCH; COMORBIDITY; CROSS-CULTURAL COMPARISON; FOUNDATIONS; GASTROINTESTINAL DISEASES; HUMANS; INTERNATIONALITY; QUALITY OF LIFE; RESEARCH REPORT; ROME;

EID: 84907982350     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12942     Document Type: Article

References (31)

1. Sperber AD, Gwee KA, Hungin AP, et al. Rome Foundation Working Team Report on Conducting Multinational, Cross-cultural Research in the Functional GI Disorders and Fostering Multinational Research Networks, 2014.
2. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17: 643-50.
3. Zuckerman MJ, Guerra LG, Drossman DA, Foland JA, Gregory GG. Comparison of bowel patterns in Hispanics and no-Hispanic whites. Dig Dis Sci 1995; 40: 1763-9.
4. Sperber AD, Friger M, Shvartzman P, et al. Rates of functional bowel disorders among Israeli Bedouins in rural areas compared to those who moved to permanent towns. Clin Gastroenterol Hepatol 2005; 3: 342-8.
5. Seifert B, Rubin G, de Wit N, et al. The management of common gastrointestinal disorders in general practice A survey by the European Society for Primary Care Gastroenterology (ESPCG) in six European countries. Dig Liver Dis 2008; 40: 659-66.
6. Gwee KA, Bak YT, Ghoshal UC, et al. Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25: 1189-205.
7. Kanazawa M, Whitehead WE, Palsson OS, et al. Medical care for irritable bowel syndrome (IBS) in Japan compared to the US. Gastroenterology 2012; 142: S10.
8. Kellow J, Lee OY, Chang FY, et al. An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome. Gut 2003; 52: 671-6.
9. Muller-Lissner S, Rykx A, Kerstens R, Vandeplassche L. A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation. Neurogastroenterol Motil 2010; 22: 991-8.
10. Gerson MJ, Gerson CD, Awad RA, et al. An international study of irritable bowel syndrome: family relationships and mind-body attributions. Soc Sci Med 2006; 62: 2838-47.
11. Schmulson M, Corazziari E, Ghoshal UC, et al. A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome Foundation Working Team on cross-cultural, multinational research. Neurogastroenterol Motil 2014; [Aug 4, 2014 Epub ahead of printing].
12. Shah SS, Bhatia SJ, Mistry FP. Epidemiology of dyspepsia in the general population in Mumbai. Indian J Gastroenterol 2001; 20: 103-6.
13. United Nations. Household Sample Surveys in Developing and Transition Countries. New York, NY: Department of Economic and Social Affairs. Statistics Division, 2005. Report No.: ST/ESA/STAT/SER.F/96.
14. Longstreth GF, Thompson WG, Chey WD. Appendix C. Rome III diagnostic questionnaire for the adult functional GI disorders (including alarm questions) and scoring algorithm. In: Drossman D. A., Corazziari E., Delvaux M., Spiller R. C., Talley N. J., Thompson W. G., Whitehead W. E. eds. Rome III. The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates, Inc., 2006; 487-555.
15. Sperber AD, Carmel S, Atzmon Y, et al. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. Am J Gastroenterol 2000; 95: 995-8.
16. Drossman DA, Li Z, Toner BB, et al. Functional Bowel Disorders. A multicenter comparison of health status and development of illness severity index. Dig Dis Sci 1995; 40: 986-95.
17. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402.
18. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF- 36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
19. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998; 43: 400-11.
20. Derogatis LR. SCL-90-R. Maryland. Towson, MD: Clinical Psychometric Research, 1983.
21. Palsson OS, Jones KR, Turner MJ, Drossman DA, Whitehead WE. Development of specific questionnaires to assess somatization and comorbid diagnosis in irritable bowel syndrome (IBS). Gastroenterology 2002; 122 (Suppl. 1): A502.
22. Toner BB, Stuckless N, Ali A, Downie F, Emmott S, Akman D. The development of a cognitive scale for functional bowel disorders. Psychosom Med 1998; 60: 492-7.
23. Kulis D, Arnott M, Greimel ER, Bottomley A, Koller M. Trends in translation requests and arising issues regarding cultural adaptation. Expert Rev Pharmacoecon Outcomes Res 2011; 11: 307-14.
24. Sperber AD, DeVellis RF, Boehlecke B. Cross-cultural translation: methodology and validation. J Cross Cult Psychol 1994; 25: 501-24.
25. Diaz-Loving R. Contributions of Mexican ethnopsychology to the resolution of the etic-emic dilemma in personality. J Cross Cult Psychol 1998; 29: 104-18.
26. Brislin RW. Translation and content analysis of oral and written material. In: Triandis HC, Berry JW, eds. Handbook of Cross-Cultural Psychology. Boston: Allyn and Bacon, 1980: 389-444. Chapter 10.
27. Brislin R, Lonner W, Thorndike R. Questionnaire wording and translation. In: Brislin R., Lonner W., Thorndike R. eds. Cross-cultural research methods. New York: Wiley, 1973: 32-58.
28. Prince R, Mamboour W. A technique for improving linguistic equivalence in cross-cultural surveys. Int J Soc Psychiatry 1967; 13: 229-37.
29. Conway K, Acquadro C, Patrick DL. Usefulness of translatability assessment: results from a retrospective study. Qual Life Res 2014; 23: 1199-210.
30. Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005; 8: 94-104.
31. FDA & US Department of Health and Human Services. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Silver Spring, MD: US Department of Health and Human Services, 2009.